Concurrent Technologies: Strong order book, strong backlog and prepared for growth (LON:CNC) 29 September 2022
Pennant International expecting to return to a positive cash balance in 2023 (LON:PEN) 29 September 2022
Guild Esports “large sponsorship contract provides significant momentum” says Zeus Capital 19 January 2022
Accrol Group “holds a strategically important position in the industry” says Zeus Capital 19 January 2022
Kenmare Resources in ‘strongest ever position’ with extremely strong pricing says Davy analyst 17 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Wizz Air Holdings (WIZZ.L): Investor Outlook Amidst Volatile Price Targets and Robust Growth 13 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Exploring a 9% Potential Upside in the Building Products Sector 13 February 2026
Worldwide Healthcare Trust PLC (WWH.L): Analyzing the Path Forward with a Singular Buy Rating 13 February 2026
TBC Bank Group PLC (TBCG.L) Investor Outlook: Potential 21.81% Upside and Robust Dividend Yield 13 February 2026
Concurrent Technologies: Strong order book, strong backlog and prepared for growth (LON:CNC) 29 September 2022
Pennant International expecting to return to a positive cash balance in 2023 (LON:PEN) 29 September 2022
Guild Esports “large sponsorship contract provides significant momentum” says Zeus Capital 19 January 2022
Accrol Group “holds a strategically important position in the industry” says Zeus Capital 19 January 2022
Kenmare Resources in ‘strongest ever position’ with extremely strong pricing says Davy analyst 17 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Wizz Air Holdings (WIZZ.L): Investor Outlook Amidst Volatile Price Targets and Robust Growth 13 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Exploring a 9% Potential Upside in the Building Products Sector 13 February 2026
Worldwide Healthcare Trust PLC (WWH.L): Analyzing the Path Forward with a Singular Buy Rating 13 February 2026
TBC Bank Group PLC (TBCG.L) Investor Outlook: Potential 21.81% Upside and Robust Dividend Yield 13 February 2026
BioNTech SE (BNTX) Stock Analysis: Navigating a 46.33% Potential Upside in the Biotechnology Sector 15 December 2025
Solventum Corporation (SOLV) Stock Analysis: Evaluating the 1.67% Potential Upside in Healthcare 15 December 2025
Hologic, Inc. (HOLX) Investor Outlook: Stability in Women’s Health Sector with Modest Upside 15 December 2025
CVS Health Corporation (CVS) Stock Analysis: Unpacking an 18% Upside Potential for Investors 15 December 2025
Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 21 Buy Ratings and a Promising Pipeline 15 December 2025
Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 55.64% Potential Upside in the Health Information Sector 15 December 2025
Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector 15 December 2025
Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Revenue Challenges 15 December 2025
Incyte Corporation (INCY): Analyst Ratings Highlight Growth Potential Amid Market Volatility 15 December 2025
Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 2.43% Potential Upside 15 December 2025
Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings 15 December 2025
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Deep Dive into its 23.94% Potential Upside 15 December 2025
Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the 5.61% Upside Potential 15 December 2025
Encompass Health Corporation (EHC) Stock Analysis: A Compelling 31% Upside Potential with Strong Buy Ratings 15 December 2025
Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 18.46% Potential Upside for Investors 15 December 2025
Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 15% Upside Potential 15 December 2025
Insmed Incorporated (INSM) Stock Analysis: Unveiling a 14% Potential Upside in the Biotech Sector 15 December 2025
Glencore Plc appoints María Margarita Zuleta as an Independent Non-Executive Director 19 February 2025
Concurrent Technologies: Strong order book, strong backlog and prepared for growth (LON:CNC) 29 September 2022
Pennant International expecting to return to a positive cash balance in 2023 (LON:PEN) 29 September 2022
Guild Esports “large sponsorship contract provides significant momentum” says Zeus Capital 19 January 2022
Accrol Group “holds a strategically important position in the industry” says Zeus Capital 19 January 2022
Kenmare Resources in ‘strongest ever position’ with extremely strong pricing says Davy analyst 17 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Wizz Air Holdings (WIZZ.L): Investor Outlook Amidst Volatile Price Targets and Robust Growth 13 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Exploring a 9% Potential Upside in the Building Products Sector 13 February 2026
Worldwide Healthcare Trust PLC (WWH.L): Analyzing the Path Forward with a Singular Buy Rating 13 February 2026
TBC Bank Group PLC (TBCG.L) Investor Outlook: Potential 21.81% Upside and Robust Dividend Yield 13 February 2026
